THE Therapeutic Goods Administration (TGA) is developing a new policy on the use of the terms "natural" and "naturally derived" after a meeting of the Therapeutic Goods Advertising Consultative Committee (TGACC) last month.
TGACC members agreed that further guidance was necessary in providing clarity on the use of these terms, and assisting consumers to make informed decisions.
Other key matters discussed included the challenge of working in an increasingly digital environment.
"Of particular concerns are issues associated with internet advertising and the fast pace of social media," with the Committee urging the development of additional educational resources addressing the application of the Advertising Code to online testimonials and paid social media influencers.
The TGA said it would develop fact sheets to address the issues.
Other items on the agenda included discussions of the interface between cosmetic and therapeutic products; in particular items containing sunscreens.
TGACC members also discussed delays in advertising pre-approval processes and the transparency of information about complaint outcomes, with the meeting requesting some changes to case management such as a "stop clock" being applied to performance deadlines where court action or external advice is in progress.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 Apr 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Apr 19